SAFE-BioPharma opens competition for 'Digi' digital-identity award
Nonprofit seeks to raise profile of the value of industry-wide identity-authentication standards
About 35 pharma manufacturers, distributors and organizations involved with healthcare delivery are now member of SAFE-BioPharma Assn., a Teaneck, NJ-based nonprofit set up to develop standards for digital-identity verification and trust. As more and more of industry activities move to cloud-based applications, the complexity of managing access, protecting against intrusions and ensuring data integrity multiplies; SAFE-BioPharma is meant to address these concerns. Its original focus among clinical investigators and researchers has now broadened to include aspects of pharmaceutical distribution and prescribing, including the DEA-managed controlled-substances ordering system (CSOS).
To highlight this growing need, SAFE-BioPharma has organized an awards competition, says Mollie Shields-Ueling, CEO of the association, open through January 15 for nominees. Categories include innovative implementations; regulatory advances; and innovative compliance initiatives. “Data exchange among pharma companies and the businesses and individuals they interact with remain a Tower of Babel, costing the industry time, money and effort,” she says.
More information is available at the SAFE-BioPharma website.
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
July 7th 2025A qualitative study explores how MA plan leaders, kidney care managers, and dialysis providers perceive the benefits, risks, and marketing practices surrounding MA enrollment for patients with end-stage kidney disease.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.
